Researcher.Life Logo

CNS Drugs : Impact Factor & More

eISSN: 1179-1934pISSN: 1172-7047

Key Metrics

CiteScore
9.8
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Neurology (clinical)
SNIP
1.87
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on CNS Drugs

CNS Drugs Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ADIS INT LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in CNS Drugs ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in CNS Drugs

Opioid Use Disorder Treatment Gaps and Emerging Therapeutics to Address Them.
  • 19 May 2026
  • CNS drugs
Enhancing Drug Response Prediction in Epilepsy with Emerging Multimodal Models: Focus on Clinical, Pharmacologic, and Genomic Factors.
  • 16 May 2026
  • CNS drugs
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review.
  • 16 May 2026
  • CNS drugs
Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes".
  • 14 May 2026
  • CNS drugs
Authors' Reply to Damkier: Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta Analysis of Congenital Malformations and Prenatal Outcomes".
  • 14 May 2026
  • CNS drugs
Correction: Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes.
  • 14 May 2026
  • CNS drugs
Opioid Use Disorder Treatment Gaps and Emerging Therapeutics to Address Them.
  • 19 May 2026
  • CNS drugs
Enhancing Drug Response Prediction in Epilepsy with Emerging Multimodal Models: Focus on Clinical, Pharmacologic, and Genomic Factors.
  • 16 May 2026
  • CNS drugs
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review.
  • 16 May 2026
  • CNS drugs
Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes".
  • 14 May 2026
  • CNS drugs
Authors' Reply to Damkier: Comment on "Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta Analysis of Congenital Malformations and Prenatal Outcomes".
  • 14 May 2026
  • CNS drugs
Correction: Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes.
  • 14 May 2026
  • CNS drugs

FAQs on CNS Drugs